Efficacy and safety of sitagliptin add-on therapy in Japanese patients with type 2 diabetes on insulin monotherapy

Introduction This multicenter, randomized study assessed the efficacy and safety of the dipeptidyl peptidase 4 inhibitor sitagliptin added to insulin monotherapy in Japanese patients with type 2 diabetes mellitus (T2DM).